£85.57

Research Progress in Alzheimer's Disease And Dementia: 1: v. 1: Volume 1

General Medical Issues

Price data last checked 100 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£86 today · usual range £0–£0 · best ever £71

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 631 days • 631 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 631 days • 10 price levels

Days at Price

Current Price

Price Analysis

Most common price: £83 (257 days, 40.7%)

Price range: £71 - £90

Price levels: 10 different prices over 631 days

Description

Alzheimer's disease (AD) is the most common type of neurodegenerative disorder in the ageing population, with dementia as a common consequence. AD is defined pathologically by the appearance of extracellular senile plaques and intracellular neurofibrillary tangles, as described by Alois Alzheimer about a century ago. The causes for AD include genetic predisposition in a small population, ageing and environmental stresses in majority cases. The underlying pathogenic cascades, increases in expression of amyloid precursor protein and accumulation of Aß and reactive oxidant activity and inflammation, have the features of both adaptive, at least initially, and harmful when becoming excessive. Dementia, on the other hand, is a clinical diagnosis and is defined as globally, persistently impaired cognitive skills including memory. Alzheimer dementia refers to clinical dementia in patients who also have Alzheimer neuropathology. Alzheimer dementia is what brings the patients to seek medical treatments. An extraordinary inability to form new memory, especially of those episodic type, and executive dysfunction are among the earliest symptoms in AD patients. In end-stage AD, cognitive degeneration extends far beyond memory loss. The underlying causes include decreases in impaired brain metabolism, which results in impaired synaptic functions and capacities, thus impaired information processing, and eventually leads to neuronal injury and death. This book presents leading-edge research in this dynamic field. About the Author Miao-Kun Sun, Ph.D. obtained his Ph.D. at the Department of Pharmacology, University of Virginia, in 1986, and continued postdoctoral research at the same department for two more years. After a brief research period (one year) at the Department of Physiology, Royal Free Hospital School of Medicine, University College of London, he accepted a faculty position at Department of Neurology and Neuroscience, Cornell University Medical College in New York in 1990. His current position is Professor at Blänchette Rockefeller Neurosciences Institute (holding the same position since 2000).

Product Specifications

Format: hardcover
ASIN: 1594549494
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues
Domain: Amazon UK
Release Date: 28 June 2007
Listed Since: 13 February 2007

Barcode

No barcode data available

Research Progress in Alzheimer's Disease And Dementia: 1: v. 1: Volume 1

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Cognition and Mood Interactions

ALZHEIMERS DISEASE RESEARCH COMPENDIUM (Neurodegenerative Diseases: Laboratory and Clinical Research; Neuroscience Research Progress)

Neuroprotection in Alzheimer's Disease

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4

Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)

Early Detection of Alzheimer’s Disease: Biological and Technological Advances

The Biology of Alzheimer Disease (Cold Spring Harbor Perspectives in Medicine)

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Molecular Mechanisms of Dementia (Contemporary Neuroscience)

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics

Mitochondrial Neuropathies: Volume 145 (International Review of Neurobiology, Volume 145)

Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)

Computational and Experimental Studies in Alzheimer's Disease

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Alzheimer's Disease and Related Disorders: Etiology, Pathogenesis and Therapeutics

Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic (Contemporary Neuroscience)

CNS Neuroprotection: 155 (Handbook of Experimental Pharmacology, 155)

Translational Neuroscience: Fundamental Approaches for Neurological Disorders

Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)